MYXR — Mycelx Technologies Balance Sheet
0.000.00%
- £6.82m
- £5.89m
- $4.90m
Annual balance sheet for Mycelx Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | USG | USG | USG | USG | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 3.29 | 3.13 | 1.65 | 0.383 | 1.26 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1.48 | 2.04 | 2.78 | 2.07 | 1.76 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 11.1 | 10.2 | 8.48 | 6.19 | 7.18 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 7.24 | 4.71 | 4.41 | 3.44 | 2.16 |
Net Intangible Assets | |||||
Total Assets | 19.1 | 15.7 | 13.6 | 10.4 | 10 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3.52 | 1.82 | 1.9 | 2.63 | 3.91 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 5.34 | 3.04 | 2.79 | 3.23 | 4.79 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 13.8 | 12.6 | 10.8 | 7.16 | 5.26 |
Total Liabilities & Shareholders' Equity | 19.1 | 15.7 | 13.6 | 10.4 | 10 |
Total Common Shares Outstanding |